Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives
- 1 September 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 35 (9), 612-614
- https://doi.org/10.1111/j.2042-7158.1983.tb04349.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Comparative evaluation of some pharmacological properties and side effects of d-glucitol hexanicotinate (sorbinicate) and nicotinic acid correlated with the plasma concentration of nicotinic acidAtherosclerosis, 1980
- Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic diseaseAtherosclerosis, 1979
- Prostaglandins contribute to the vasodilation induced by nicotinic acidProstaglandins, 1979
- Studies on the Mechanism of Flush Induced by Nicotinic AcidActa Pharmacologica et Toxicologica, 1977
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975
- Clofibrate and niacin in coronary heart diseaseJAMA, 1975
- Influence of nicotinic acid and pentaerythritoltetranicotinate (Perycit®, Bofors) on the cardiac output in manEuropean Journal of Clinical Pharmacology, 1970
- The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in manClinical Pharmacology & Therapeutics, 1969
- Inhibition of cholesterol-induced vascular lesions by dietary reserpineJournal of Atherosclerosis Research, 1968
- A PRESSOR RESPONSE OF THE RABBIT TO NICOTINIC ACIDBritish Journal of Pharmacology and Chemotherapy, 1966